Study Reports Effectiveness of BBV152 Against COVID-19 By Music World November 25, 2021 The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19. from Medindia Health News https://ift.tt/3HVqnkL via Share Get link Facebook X Pinterest Email Other Apps Labels Medindia Health News Share Get link Facebook X Pinterest Email Other Apps Comments
The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19.
Comments
Post a Comment